Ernexa Therapeutics
(NASDAQ) BTX
Ernexa Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$14.08
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BTX News
BTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ernexa Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Sanjeev Luther, MBA
Website
www.ernexatx.comHeadquarters
San Diego, CA 92121, US
BTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
88%
Net Income Margin
88%
Return on Equity
3%
Return on Capital
4%
Return on Assets
4%
Earnings Yield
N/A
Dividend Yield
12.53%
Payout Ratio
4.30%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$40.69M
Operating Income
$35.70M
EBITDA
$0.00
Operating Cash Flow
$877.82M
Capital Expenditure
$0.00
Free Cash Flow
$877.82M
Cash & ST Invst.
$449.08K
Total Debt
$0.00
Ernexa Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+0.0%
Gross Profit
$0.07
+1.0%
Gross Margin
-6700.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
$1.88
N/A
Employees
5
N/A
Net Income
$1.50
+0.3%
EBITDA
$2.02
+0.8%
Quarterly Fundamentals
Net Cash
$1.88
+1.1%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.28
+0.6%
Short Term Debt
$0.21
+1.0%
Return on Assets
-253.68%
+1.5%
Return on Invested Capital
-489.37%
+5.7%
Free Cash Flow
$1.16
+0.3%
Operating Cash Flow
$1.15
+0.3%